OnKure Therapeutics, Inc.

Stock Chart, Company Information, and Scan Results

$3.99(as of Mar 27, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

OnKure Therapeutics, Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$3.99
Ticker SymbolOKUR
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees45
CountyUSA
Market Cap$54.6M

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.

OnKure Therapeutics, Inc. In Our Stock Scanner

As of Mar 30, 2026
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Low PB RatioScan Type: Stock Fundamentals
As of ---
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.